Genes Outside Nucleus Have Disproportionate Effect
By Science Daily,
Science Daily
| 10. 12. 2013
Oct. 12, 2013 — New research from the University of California, Davis, shows that the tiny proportion of a cell's DNA that is located outside the cell nucleus has a disproportionately large effect on a cell's metabolism. The work, with the model plant Arabidopsis, may have implications for future treatments for inherited diseases in humans.
Plant and animal cells carry most of their genes on chromosomes in the nucleus, separated from the rest of the cell. However, they also contain a small number of genes in organelles that lie outside the nucleus. These are the mitochondria, which generate energy for animal and plant cells, and chloroplasts, which carry out photosynthesis in plant cells.
The influence of genes outside the nucleus was known to an earlier generation of field ecologists and crop breeders, said Dan Kliebenstein, professor in the UC Davis Department of Plant Sciences and Genome Center and senior author on the paper published Oct. 8 in the online journal eLife. This is the first time that the effect has been quantified with a genomic approach, he said.
Bindu Joseph...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...